JOURNAL OF CLINICAL IMMUNOLOGY

Scope & Guideline

Exploring the Dynamics of Immune Responses

Introduction

Explore the comprehensive scope of JOURNAL OF CLINICAL IMMUNOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF CLINICAL IMMUNOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0271-9142
PublisherSPRINGER/PLENUM PUBLISHERS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1981 to 2024
AbbreviationJ CLIN IMMUNOL / J. Clin. Immunol.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address233 SPRING ST, NEW YORK, NY 10013

Aims and Scopes

The Journal of Clinical Immunology primarily focuses on the spectrum of clinical immunology, with a significant emphasis on inborn errors of immunity, autoimmune diseases, and immunodeficiency disorders. The journal serves as a platform for disseminating research findings that advance our understanding of immune system disorders and their management.
  1. Inborn Errors of Immunity (IEI):
    The journal extensively covers research on genetic and phenotypic aspects of inborn errors of immunity, including their clinical presentations, treatment options, and long-term outcomes.
  2. Autoimmunity and Immune Dysregulation:
    Research articles focusing on autoimmune diseases, the mechanisms underlying autoimmunity, and the impact of immune dysregulation on patient health are predominant, highlighting both clinical and molecular insights.
  3. Transplantation and Immune Reconstitution:
    Studies related to hematopoietic stem cell transplantation (HSCT) and its effects on immune reconstitution in patients with various immunodeficiencies are a key focus area, including novel conditioning regimens and post-transplant care.
  4. Immunotherapy and Novel Treatments:
    The journal features articles on innovative therapeutic approaches, including immunotherapy, monoclonal antibodies, and gene therapy, aimed at managing immune disorders.
  5. Clinical Research and Patient Outcomes:
    There is a strong emphasis on clinical studies that evaluate patient outcomes, quality of life, and health care utilization among those with immunological disorders.
The Journal of Clinical Immunology has identified several emerging themes in recent years, reflecting the evolving landscape of clinical immunology and the growing complexity of managing immune disorders. These themes signify a shift towards more personalized medicine and advanced therapeutic strategies.
  1. Genetic Insights into Immunodeficiencies:
    There is a notable increase in research focused on the genetic basis of immunodeficiencies, with a growing emphasis on identifying novel mutations and understanding their clinical implications.
  2. Impact of COVID-19 on Immunocompromised Patients:
    The journal has seen a surge in studies investigating the effects of COVID-19 on patients with inborn errors of immunity, including vaccine responses and management strategies during the pandemic.
  3. Machine Learning and Data-Driven Approaches:
    Emerging trends include the application of machine learning and data mining techniques to predict outcomes in immunodeficiency patients, enhancing diagnostic accuracy and treatment personalization.
  4. Longitudinal Studies on Immune Dysregulation:
    There is an increasing focus on longitudinal studies that assess the long-term effects of immune dysregulation and its management, particularly in chronic conditions such as common variable immunodeficiency.
  5. Personalized and Targeted Therapies:
    The journal is increasingly publishing research on personalized treatment approaches, including targeted therapies and novel immunomodulatory treatments that aim to optimize patient outcomes.

Declining or Waning

While the Journal of Clinical Immunology has a strong focus on emerging themes in immunology, certain topics appear to be declining in prominence over the recent years. This may reflect a shift in research interest or advancements in understanding that have rendered previous areas less critical.
  1. Traditional Immunodeficiency Diagnostics:
    The focus on conventional diagnostic approaches for immunodeficiencies, such as serum immunoglobulin levels, is decreasing as more advanced genetic and molecular diagnostics gain traction.
  2. General Case Reports:
    There appears to be a waning interest in publishing general case reports without significant novel insights or broader implications for clinical practice, shifting towards more comprehensive studies.
  3. Basic Immunology Studies:
    Research that primarily explores basic immunological principles without direct clinical applications or implications for patient care is less frequently published, as the journal increasingly prioritizes clinically relevant findings.

Similar Journals

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Unveiling New Horizons in Immune Mechanisms and Treatments.
Publisher: SAGE PUBLICATIONS INCISSN: 0394-6320Frequency: 1 issue/year

Welcome to the International Journal of Immunopathology and Pharmacology, a premier publication dedicated to advancing the fields of immunology and pharmacology. Published by SAGE Publications Inc., this Open Access journal has been a vital resource since its inception in 1989, providing an expansive platform for innovative research and comprehensive reviews until 2024. With a strong focus on the mechanisms of immune responses and therapeutic developments, our journal stands out with a 2023 impact factor reflected in its Q3 ranking in Immunology and Allergy, and a Q2 ranking in Pharmacology. The journal's Scopus rankings highlight its significance, ranking #174 in Pharmacology, #141 in Medicine, and #156 in Immunology, all affirming its role in contributing to the broader scientific community. Through rigorous peer review and a commitment to high-quality research, the International Journal of Immunopathology and Pharmacology continues to be an essential resource for scientists, healthcare professionals, and students striving to enhance their knowledge and understanding in these critical fields.

JOURNAL OF IMMUNOLOGY

Unveiling the Secrets of Immunity
Publisher: AMER ASSOC IMMUNOLOGISTSISSN: 0022-1767Frequency: 24 issues/year

Welcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.

Immuno

Exploring the Frontiers of Immunology and Beyond
Publisher: MDPIISSN: Frequency: 4 issues/year

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

Journal of Immunology Research

Connecting Researchers: Elevating the Study of Immunology Worldwide
Publisher: HINDAWI LTDISSN: 2314-8861Frequency:

Journal of Immunology Research, published by HINDAWI LTD, stands as a pivotal open-access journal in the realm of immunology, with a particular emphasis on advancing knowledge in both fundamental and applied aspects of the field. Since its inception in 1990, the journal has committed to the dissemination of high-quality research, earning a respectable impact factor that reflects its significance. Based in Egypt, it provides a platform for researchers from around the world, showcasing innovative studies and reviews that contribute to the understanding of immune system mechanisms. Its 2023 rankings place it in the Q2 category for Immunology and Allergy, and Q1 in the broader category of Medicine (miscellaneous), indicating a strong reputation among its peers. Through its open-access model, the journal promotes wide accessibility of cutting-edge research, catering to researchers, professionals, and students alike. With ambitions that converge through 2024, the Journal of Immunology Research continues to be an essential resource for those seeking to explore the forefront of immunological science.

IMMUNOLOGICAL INVESTIGATIONS

Exploring the Frontiers of Immunological Science
Publisher: TAYLOR & FRANCIS INCISSN: 0882-0139Frequency: 8 issues/year

IMMUNOLOGICAL INVESTIGATIONS, published by Taylor & Francis Inc, is a leading journal in the field of immunology and related medical sciences, with an established presence since 1972. With a focus on cutting-edge research and critical insights in immunological methods and theories, this journal serves as a pivotal platform for researchers, professionals, and students alike. Though it currently holds a Q3 ranking in Immunology and a Q2 ranking in miscellaneous medicine as of 2023, its Scopus rank of #129 out of 236 reflects its dedication to advancing the understanding of immune responses and therapies. The journal's commitment to rigorous peer review and high-quality publications enables it to remain relevant and influential in the ever-evolving landscape of immunological research. Subscription is required to access its extensive archive, which spans critical developments in the field of immunology from 1972 to 2024.

Immunotherapy Advances

Pioneering research that shapes the future of patient care.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 1 issue/year

Immunotherapy Advances, published by Oxford University Press, stands at the forefront of the rapidly evolving field of immunology and microbe interactions, focusing specifically on novel immunotherapeutic strategies and their clinical applications. Established in 2021, this peer-reviewed journal aims to disseminate high-quality research that contributes to the understanding and advancement of immunotherapeutic techniques, potentially transforming patient care in immunology. With a current Scopus rank of #140 out of 236 in the realm of Immunology, placing it in the 40th percentile, Immunotherapy Advances is positioned to be an integral resource for researchers, healthcare professionals, and students eager to stay updated with groundbreaking findings and methodologies. The journal is dedicated to fostering innovative discussions and collaborations, ensuring open access to vital research that influences treatment paradigms globally.

Current Allergy & Clinical Immunology

Pioneering knowledge in allergy medicine.
Publisher: ALLERGY SOC SOUTH AFRICAISSN: 1609-3607Frequency: 4 issues/year

Current Allergy & Clinical Immunology is a vital peer-reviewed journal published by the Allergy Society of South Africa, focused on advancing the field of immunology and allergy medicine. With an ISSN of 1609-3607, this journal offers crucial insights and research findings pertinent to the understanding and treatment of allergic conditions. Operating from South Africa, it features contributions from a diverse range of authors and professionals in the field. Published from 2008 to 2024, the journal plays an essential role in disseminating current knowledge, even as it holds a Q4 ranking in Immunology and Allergy and is positioned at the 4th percentile based on Scopus rankings. While not open access, it remains an important resource for researchers, practitioners, and students looking to stay informed on emerging trends and breakthroughs in allergy and clinical immunology.

IMMUNOLOGY AND CELL BIOLOGY

Connecting Researchers in the Realm of Immunology and Cell Science
Publisher: WILEYISSN: 0818-9641Frequency: 10 issues/year

IMUNOLOGY AND CELL BIOLOGY, published by Wiley, serves as a prominent platform for disseminating cutting-edge research in the fields of immunology and cell biology. With an ISSN of 0818-9641 and an E-ISSN of 1440-1711, this journal has established itself since its inception in 1987, demonstrating a commitment to advancing knowledge in its disciplines through high-quality articles. Renowned for its rigorous peer-review process, it holds a Q2 quartile ranking in both immunology and cell biology categories as of 2023, showing its competitive stature in these fields. IMUNOLOGY AND CELL BIOLOGY is indexed among the elite journals worldwide, with impressive Scopus rankings, including a rank of #75/233 in Immunology and Allergy. The journal’s comprehensive scope ensures that it caters to an audience of researchers, professionals, and students who are dedicated to exploring the intricate mechanisms of immune responses and cellular interactions. Although it does not operate under an open access model, its subscription-based content remains invaluable for those seeking to broaden their understanding of immunology and cell biology. By providing a forum for significant scientific dialogue, IMUNOLOGY AND CELL BIOLOGY continues to shape the future of research in these vital areas.

Cellular & Molecular Immunology

Unraveling the Mysteries of Immunity
Publisher: CHIN SOCIETY IMMUNOLOGYISSN: 1672-7681Frequency: 12 issues/year

Cellular & Molecular Immunology is a prestigious peer-reviewed journal published by the CHIN SOCIETY IMMUNOLOGY. As a leading journal in the fields of immunology and infectious diseases, it proudly holds a Q1 designation across multiple categories, including Immunology, Allergy, and Medicine (Miscellaneous), reflecting its commitment to excellence and impactful research. With an ISSN of 1672-7681 and an E-ISSN of 2042-0226, the journal has been essential reading since its inception in 2004, continuously gathering insights from cutting-edge studies. It ranks impressively within Scopus, with positions in the 7th, 8th, and 9th percentile in relevant categories, establishing it as a cornerstone for researchers, clinicians, and students alike. The journal offers an extensive range of original research articles, reviews, and clinical studies, ensuring that readers stay at the forefront of immunological discovery. Whether you are interested in basic immunology, infectious diseases, or evolving therapies, Cellular & Molecular Immunology serves as an invaluable resource for advancing your knowledge and engagement in this dynamic field.

GENES AND IMMUNITY

Advancing the Frontiers of Genetics and Immunology
Publisher: SPRINGERNATUREISSN: 1466-4879Frequency: 8 issues/year

GENES AND IMMUNITY, published by SpringerNature, is a leading scholarly journal dedicated to advancing the field of genetics and immunology. With an impressive impact factor and a distinguished ranking in the Q1 quartile of both Genetics and Immunology disciplines for 2023, this journal serves as a pivotal platform for researchers and professionals looking to explore the intricate relationships between genetic factors and immune responses. Established in 1999 and continuously published until 2024, it features high-quality peer-reviewed research articles, reviews, and commentary that address critical issues and recent advancements in the field. The journal adheres to rigorous academic standards, evidenced by its strong Scopus rankings, making it a valuable resource for students, researchers, and practitioners alike who are seeking to deepen their understanding of genetics' role in immunity. For those looking to keep abreast of cutting-edge insights, GENES AND IMMUNITY is an essential read.